The global downstream
processing market is poised to reach $22.03 Billion by 2021 from $10.32 Billion in 2016,
at a CAGR of 16.4%. The growth of this market is propelled by the increasing
demand for biopharmaceuticals and increasing R&D expenditure in the
biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new
growth opportunities to players in the market.
The Asia-Pacific region is expected to grow at the highest CAGR during the
forecast period. Countries like China, Japan, India, and South Korea, are
expected to drive the demand for downstream processing products in the coming
years. Also, growth in these markets will be fueled by significant investments
by key market players, increasing government support, developing R&D
infrastructure, and growing expertise and academic excellence.
North America is the world’s largest pharmaceutical market and a leader in
biopharmaceutical research. North America (comprising the U.S. and Canada)
accounted for the largest share of the global market in 2016. Rising quality
requirements have emphasized the need for advanced bioproduction technology in
this region.
Downstream Processing Market, by
Product:
1. Chromatography Columns and Resins
2. Filters
3. Membrane Adsorbers
4. Single-use Products
5. Other Products (Consumables and Accessories)
On the basis of product, the market is classified into chromatography columns
and resins, filters, membrane adsorbers, single-use products, and other
products. In 2016, the chromatography columns and resins segment accounted for
the largest share of the market. The constant need for newer and different
types of columns and resins is likely to fuel market growth.
Get Crucial Industry Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930
Based on application, the downstream
processing market is categorized into monoclonal antibody (mAbs)
production, vaccine production, insulin production, immunoglobulin production,
erythropoietin production, and other applications. In 2016, the vaccine
production segment accounted for the largest share of the market. Technological
advancement in the downstream purification technology to develop high-quality
products such as Vaccines at lower costs is expected to drive the
growth of this segment.
Key
Players in Downstream Processing Market:
The Downstream Processing Market is dominated by
established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare
(U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and
Danaher Corporation (U.S.).
Downstream Processing Market, by End
User:
1. Biopharmaceutical Manufacturers
2. Contract Manufacturing Organizations (CMOs)
Based on end user, the market is segmented into biopharmaceutical manufacturers
and contract manufacturing organizations (CMOs). In 2016, the biopharmaceutical
manufacturers segment accounted for the largest share of the market. The
increasing demand for biopharmaceuticals among the aging population is expected
to accelerate the growth of the biopharmaceutical manufacturers’ end-user
segment.
Know more Insights:
https://www.marketsandmarkets.com/Market-Reports/downstream-processing-market-73180930.html